サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1392386

In Vitro毒性試験の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測

Global In Vitro Toxicity Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 336 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
In Vitro毒性試験の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
出版日: 2023年11月01日
発行: Value Market Research
ページ情報: 英文 336 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

In Vitro毒性試験市場の世界需要は、調査期間2023～2030年のCAGR12.42%で、2022年の1,346万米ドルから2030年にはほぼ3,434万米ドルの市場規模に達すると推定されます。

In Vitro毒性試験は、培養細菌または哺乳類細胞に対する有毒化学物質の影響を調査に基づいて評価するものです。試験管内試験（in glass）は、通常の生物学的条件以外の微生物、細胞、または生物学的分子に対して行われます。試験管内で薬物を試験する場合、薬物の濃度は既知の量に制限されます。すべての薬物の挙動評価は基本的に決められた割合で行われるため、これは非常に重要です。これは主に医薬品開発の安全性と化学的強度を評価するために行われます。毒性試験の目的は、環境要因への暴露による悪影響から公衆衛生を適切に保護できるデータを開発することです。

市場力学：

医薬品の安全性を評価する技術の進歩、消費財の安全性の高まり、潜在的医薬品のランク付けとスクリーニングの増加、実施される体外試験の数の増加は、In Vitro毒性試験の主な業界促進要因です。さらに、研究開発への投資の増加と動物実験への反対が、体外毒物検査を促しました。しかし、政府の厳しい規制や専門家の不足は、In Vitro毒性試験の大きな障壁となっています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、In Vitro毒性試験の世界市場における各セグメントを包括的に評価することもできます。In Vitro毒性試験産業の成長と動向は、この調査への全体的なアプローチを提供します。

地域分析：

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカにおけるIn Vitro毒性試験市場の現在と将来の需要を強調する地域展望をカバーします。さらに、本レポートは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 In Vitro毒性試験-産業分析

  • イントロダクション：市場力学
  • 市場の促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 In Vitro毒性試験の世界市場分析：製品・サービス別

  • 製品・サービス別概要
  • 実績データと予測データ
  • 製品・サービス別分析
  • Covidの影響
  • 消耗品
  • アッセイ（細菌毒性アッセイ、酵素毒性アッセイ、セルベースエリザ＆ウェスタンブロット、受容体結合アッセイ、組織培養アッセイ、その他アッセイ）
  • 装置
  • ソフトウェア
  • サービス

第7章 In Vitro毒性試験の世界市場分析：試験法別

  • 試験法別概要
  • 実績データと予測データ
  • 試験法別分析
  • 細胞アッセイ
  • 生化学的アッセイ
  • In Silicoモデル
  • Ex Vivoモデル

第8章 In Vitro毒性試験の世界市場分析：毒性エンドポイント・試験別

  • 毒性エンドポイント・試験別概要
  • 実績データと予測データ
  • 毒性エンドポイント・試験別分析
  • ADME
  • 皮膚刺激性、腐食性、感作性
  • 遺伝毒性試験
  • 細胞毒性試験
  • 眼毒性
  • 臓器毒性
  • 光毒性試験
  • 経皮毒性
  • その他

第9章 In Vitro毒性試験の世界市場分析：産業別

  • 産業別概要
  • 実績データと予測データ
  • 産業別分析
  • コビッドの影響
  • 医薬品・バイオ医薬品
  • 化粧品・家庭用品
  • 食品
  • 化学品

第10章 In Vitro毒性試験の世界市場分析：技術別

  • 技術別概要
  • 実績データと予測データ
  • 技術別分析
  • 細胞培養技術
  • ハイスループット技術
  • トキシコゲノミクス

第11章 In Vitro毒性試験の世界市場分析：地域別

  • 上位企業シェア分析
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東とアフリカ

第12章 In Vitro毒性試験企業の競合情勢

  • In Vitro毒性試験市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品上市
  • その他の開発

第13章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Thermo Fisher Scientific Inc.（米国）
  • Covance（米国）
  • Bio-Rad Laboratories Inc.（米国）
  • GE Healthcare（米国）
  • Eurofins Scientific SE（ルクセンブルグ）
  • Merck KGaA（ドイツ）
  • Charles River Laboratories International Inc.（米国）
  • Catalent Inc.（米国）
  • Cyprotex（英国）
  • SGS S.A.（スイス）
  • QIAGEN N.V.（ドイツ）
  • Promega Corporation（米国）
  • Gentronix Limited（英国）
  • BioIVT（米国）
  • MB Research Laboratories（米国）
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product & Service (USD MN)
  • Covid Impact Market Sales by Geography (USD MN)
  • Consumables Market Sales by Geography (USD MN)
  • Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based Elisa & Western Blots, Receptor-binding Assays, Tissue Culture Assays, Other Assays) Market Sales by Geography (USD MN)
  • Equipment Market Sales by Geography (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis Market by Method (USD MN)
  • Cellular Assays Market Sales by Geography (USD MN)
  • Biochemical Assays Market Sales by Geography (USD MN)
  • In Silico Models Market Sales by Geography (USD MN)
  • Ex Vivo Models Market Sales by Geography (USD MN)
  • Analysis by Toxicity Endpoint & Test (USD MN)
  • ADME Market Sales by Geography (USD MN)
  • Skin Irritation, Corrosion, & Sensitization Market Sales by Geography (USD MN)
  • Genotoxicity Testing Market Sales by Geography (USD MN)
  • Cytotoxicity Testing Market Sales by Geography (USD MN)
  • Ocular Toxicity Market Sales by Geography (USD MN)
  • Organ Toxicity Market Sales by Geography (USD MN)
  • Phototoxicity Testing Market Sales by Geography (USD MN)
  • Dermal Toxicity Market Sales by Geography (USD MN)
  • Other Toxicity Endpoints & Tests Market Sales by Geography (USD MN)
  • Analysis by Industry (USD MN)
  • Covid Impact Market Sales by Geography (USD MN)
  • Pharmaceuticals & Biopharmaceuticals Market Sales by Geography (USD MN)
  • Cosmetic & Household Products Market Sales by Geography (USD MN)
  • Food Market Sales by Geography (USD MN)
  • Chemicals Market Sales by Geography (USD MN)
  • Analysis by Technology (USD MN)
  • Cell Culture Technologies Market Sales by Geography (USD MN)
  • High-throughput Technologies Market Sales by Geography (USD MN)
  • Toxicogenomics Market Sales by Geography (USD MN)
  • Global In Vitro Toxicity Testing Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of In Vitro Toxicity Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global In Vitro Toxicity Testing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product & Service
  • Market Attractiveness Analysis by Method
  • Market Attractiveness Analysis by Toxicity Endpoint & Test
  • Market Attractiveness Analysis by Industry
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product & Service (USD MN)
  • Covid Impact Market Sales by Geography (USD MN)
  • Consumables Market Sales by Geography (USD MN)
  • Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based Elisa & Western Blots, Receptor-binding Assays, Tissue Culture Assays, Other Assays) Market Sales by Geography (USD MN)
  • Equipment Market Sales by Geography (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Method (USD MN)
  • Cellular Assays Market Sales by Geography (USD MN)
  • Biochemical Assays Market Sales by Geography (USD MN)
  • In Silico Models Market Sales by Geography (USD MN)
  • Ex Vivo Models Market Sales by Geography (USD MN)
  • Global Market Analysis by Toxicity Endpoint & Test (USD MN)
  • ADME Market Sales by Geography (USD MN)
  • Skin Irritation, Corrosion, & Sensitization Market Sales by Geography (USD MN)
  • Genotoxicity Testing Market Sales by Geography (USD MN)
  • Cytotoxicity Testing Market Sales by Geography (USD MN)
  • Ocular Toxicity Market Sales by Geography (USD MN)
  • Organ Toxicity Market Sales by Geography (USD MN)
  • Phototoxicity Testing Market Sales by Geography (USD MN)
  • Dermal Toxicity Market Sales by Geography (USD MN)
  • Other Toxicity Endpoints & Tests Market Sales by Geography (USD MN)
  • Global Market Analysis by Industry (USD MN)
  • Covid Impact Market Sales by Geography (USD MN)
  • Pharmaceuticals & Biopharmaceuticals Market Sales by Geography (USD MN)
  • Cosmetic & Household Products Market Sales by Geography (USD MN)
  • Food Market Sales by Geography (USD MN)
  • Chemicals Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Cell Culture Technologies Market Sales by Geography (USD MN)
  • High-throughput Technologies Market Sales by Geography (USD MN)
  • Toxicogenomics Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11218376

The global demand for In Vitro Toxicity Testing Market is presumed to reach the market size of nearly USD 34.34 MN by 2030 from USD 13.46 MN in 2022 with a CAGR of 12.42% under the study period 2023 - 2030.

In vitro toxicity testing is a research-based evaluation of the effects of toxic chemicals on cultured bacteria or mammalian cells. In vitro studies (i.e., in glass) are performed against microorganisms, cells, or biological molecules outside of normal biological conditions. When testing a drug in vitro, the concentration of the drug is limited to a known volume. This is critical because all drug behaviour assessments are essentially demonstrated at defined proportions. This is primarily done to assess the safety of drug development and chemical strength. The goal of toxicity testing is to develop data that can adequately protect public health from the adverse effects of exposure to environmental factors.

MARKET DYNAMICS:

The growth in technological advancement to evaluate drug safety, the upsurge in consumer goods safety, the increase in ranking and screening of potential drugs, and the rise in the number of in-vitro tests conducted are key industry drivers for in-vitro toxicology testing. In addition, increased investment in research and development and opposition to animal testing prompted in-vitro toxicology testing. However, the government's stringent regulations and a lack of professionals are significant barriers to in-vitro testing.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in vitro toxicity testing. The growth and trends of in vitro toxicity testing industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the in vitro toxicity testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

  • Covid Impact
  • Consumables
  • Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-Based Elisa & Western Blots, Receptor-Binding Assays, Tissue Culture Assays, Other Assays)
  • Equipment
  • Software
  • Services

By Method

  • Cellular Assays
  • Biochemical Assays
  • In Silico Models
  • Ex Vivo Models

By Toxicity Endpoint & Test

  • ADME
  • Skin Irritation, Corrosion, & Sensitization
  • Genotoxicity Testing
  • Cytotoxicity Testing
  • Ocular Toxicity
  • Organ Toxicity
  • Phototoxicity Testing
  • Dermal Toxicity
  • Other Toxicity Endpoints & Tests

By Industry

  • Covid Impact
  • Pharmaceuticals & Biopharmaceuticals
  • Cosmetic & Household Products
  • Food
  • Chemicals

By Technology

  • Cell Culture Technologies
  • High-Throughput Technologies
  • Toxicogenomics

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the In Vitro Toxicity Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the in vitro toxicity testing market include Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . IN VITRO TOXICITY TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Service
    • 3.7.2 Market Attractiveness Analysis By Method
    • 3.7.3 Market Attractiveness Analysis By Toxicity Endpoint & Test
    • 3.7.4 Market Attractiveness Analysis By Industry
    • 3.7.5 Market Attractiveness Analysis By Technology
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5. IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY PRODUCT & SERVICE

  • 6.1 Overview by Product & Service
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product & Service
  • 6.4 Covid Impact Historic and Forecast Sales by Regions
  • 6.5 Consumables Historic and Forecast Sales by Regions
  • 6.6 Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based Elisa & Western Blots, Receptor-binding Assays, Tissue Culture Assays, Other Assays) Historic and Forecast Sales by Regions
  • 6.7 Equipment Historic and Forecast Sales by Regions
  • 6.8 Software Historic and Forecast Sales by Regions
  • 6.9 Services Historic and Forecast Sales by Regions

7 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY METHOD

  • 7.1 Overview by Method
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Method
  • 7.4 Cellular Assays Historic and Forecast Sales by Regions
  • 7.5 Biochemical Assays Historic and Forecast Sales by Regions
  • 7.6 In Silico Models Historic and Forecast Sales by Regions
  • 7.7 Ex Vivo Models Historic and Forecast Sales by Regions

8 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY TOXICITY ENDPOINT & TEST

  • 8.1 Overview by Toxicity Endpoint & Test
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Toxicity Endpoint & Test
  • 8.4 ADME Historic and Forecast Sales by Regions
  • 8.5 Skin Irritation, Corrosion, & Sensitization Historic and Forecast Sales by Regions
  • 8.6 Genotoxicity Testing Historic and Forecast Sales by Regions
  • 8.7 Cytotoxicity Testing Historic and Forecast Sales by Regions
  • 8.8 Ocular Toxicity Historic and Forecast Sales by Regions
  • 8.9 Organ Toxicity Historic and Forecast Sales by Regions
  • 8.10. Phototoxicity Testing Historic and Forecast Sales by Regions
  • 8.11 Dermal Toxicity Historic and Forecast Sales by Regions
  • 8.12 Other Toxicity Endpoints & Tests Historic and Forecast Sales by Regions

9 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY INDUSTRY

  • 9.1 Overview by Industry
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Industry
  • 9.4 Covid Impact Historic and Forecast Sales by Regions
  • 9.5 Pharmaceuticals & Biopharmaceuticals Historic and Forecast Sales by Regions
  • 9.6 Cosmetic & Household Products Historic and Forecast Sales by Regions
  • 9.7 Food Historic and Forecast Sales by Regions
  • 9.8 Chemicals Historic and Forecast Sales by Regions

10 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY TECHNOLOGY

  • 10.1 Overview by Technology
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by Technology
  • 10.4 Cell Culture Technologies Historic and Forecast Sales by Regions
  • 10.5 High-throughput Technologies Historic and Forecast Sales by Regions
  • 10.6 Toxicogenomics Historic and Forecast Sales by Regions

11 . GLOBAL IN VITRO TOXICITY TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE IN VITRO TOXICITY TESTING COMPANIES

  • 12.1. In Vitro Toxicity Testing Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF IN VITRO TOXICITY TESTING INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Thermo Fisher Scientific Inc. (US)
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. Covance (US)
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Bio-Rad Laboratories Inc. (US)
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. GE Healthcare (US)
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. Eurofins Scientific SE (Luxembourg)
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. Merck KGaA (Germany)
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Charles River Laboratories International Inc. (US)
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Catalent Inc. (US)
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Cyprotex (UK)
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. SGS S.A. (Switzerland)
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. QIAGEN N.V. (Germany)
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. Promega Corporation (US)
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments
  • 13.15. Gentronix Limited (UK)
    • 13.15.1. Company Overview
    • 13.15.2. Company Revenue
    • 13.15.3. Products
    • 13.15.4. Recent Developments
  • 13.16. BioIVT (US)
    • 13.16.1. Company Overview
    • 13.16.2. Company Revenue
    • 13.16.3. Products
    • 13.16.4. Recent Developments
  • 13.17. MB Research Laboratories (US)
    • 13.17.1. Company Overview
    • 13.17.2. Company Revenue
    • 13.17.3. Products
    • 13.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies